A review of human heart models—cardiac organoids and organ chips—showed that each method has unique advantages in different research contexts, including cardiac disease modeling and drug development.

Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Penumbra (NYSE:PEN) and its peers. The ...

As tools become more precise and non-invasive, doctors are able to diagnose and treat heart conditions with greater accuracy and efficiency.